Gilead Sciences, Inc. today announced the presentation of late-breaking data and multiple oral presentations from its innovative HIV treatment portfolio and pipeline at the Conference on Retroviruses ...

Unsurprisingly, obese individuals (BMI 30-34.9 kg/m 2) had the highest prevalence of EVAF (88%) in the study, followed by class II obese PWH (BMI 35-40 kg/m 2; 69%). However, EVAF was still present in ...

The Ministry of Health has assured Kenyans that the country’s HIV response will remain on track despite disruptions caused by ...

Many healthcare and social services depend on international aid. Funding cuts have disrupted HIV prevention, treatment, and care programmes, putting PLHIV at higher risk of infections and severe ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

HIV incidence in sub-Saharan Africa has declined substantially, according to both UNAIDS estimates and empirical data pulled ...

Researchers from Imperial College London, working with the University of Oxford and Rockefeller University, have shown ...

Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by ...

SAN FRANCISCO -- Most patients with HIV who received two broadly neutralizing antibodies (bNAbs) after pausing antiretroviral ...

Offering mailed self-testing for HIV encouraged patients to test themselves for HIV but require methods of improving ...

Two more people have been potentially cured of HIV after receiving stem cell transplants to treat blood cancer or bone marrow ...

Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025IMC-M113V was well ...